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ABSTRACT
Mutations in ESCO2, one of two establishment of cohesion factors
necessary for proper sister chromatid cohesion (SCC), cause a
spectrum of developmental defects in the autosomal-recessive
disorder Roberts syndrome (RBS), warranting in vivo analysis of the
consequence of cohesion dysfunction. Through a genetic screen in
zebrafish targeting embryonic-lethal mutants that have increased
genomic instability, we have identified an esco2 mutant zebrafish.
Utilizing the natural transparency of zebrafish embryos, we have
developed a novel technique to observe chromosome dynamics within
a single cell during mitosis in a live vertebrate embryo. Within esco2
mutant embryos, we observed premature chromatid separation, a
unique chromosome scattering, prolonged mitotic delay, and genomic
instability in the form of anaphase bridges and micronuclei formation.
Cytogenetic studies indicated complete chromatid separation and high
levels of aneuploidy within mutant embryos. Amongst aneuploid
spreads, we predominantly observed decreases in chromosome
number, suggesting that either cells with micronuclei or micronuclei
themselves are eliminated. We also demonstrated that the genomic
instability leads to p53-dependent neural tube apoptosis. Surprisingly,
although many cells required Esco2 to establish cohesion, 10-20% of
cells hadonlyweakenedcohesion in the absenceofEsco2, suggesting
that compensatory cohesion mechanisms exist in these cells that
undergo a normal mitotic division. These studies provide a unique
in vivo vertebrate view of the mitotic defects and consequences of
cohesion establishment loss, and they provide a compensation-based
model to explain the RBS phenotypes.
KEY WORDS: esco2, Sister chromatid cohesion, In vivo imaging,
Zebrafish, p53, Genomic instability, Aneuploidy
INTRODUCTION
Sister chromatid cohesion (SCC) is a dynamic, cell-cycle-dependent
process that is essential for proper segregation of chromosomes.
A protein complex forms a cohesin ring comprised of SMC1a,
SMC3, RAD21 and STAG1/2 that is associated, or ‘loaded’, onto
DNA during the G1 phase of the cell cycle by the NIPBL andMau-2
proteins (Losada, 2008; Nasmyth and Haering, 2009; Ocampo-
Hafalla and Uhlmann, 2011). Upon entry into S-phase, as the sister
chromatids are being synthesized, the two establishment of cohesion
factors, ESCO1 and ESCO2, establish cohesion by securing the
cohesin ring around sister chromatids (Skibbens et al., 1999;
Hartman et al., 2000; Homer et al., 2005; Skibbens, 2009; Terret
et al., 2009). During mitosis, cohesion is removed in two steps: (1)
during the transition from prophase to prometaphase, cohesion
between chromatid arms is removed through the anti-establishment
pathway involving WAPAL, whereas the centromeric cohesion is
protected by establishment and/or maintenance factors, including
SGO1, SGO2 and sororin (Salic et al., 2004; Rankin et al., 2005;
Gandhi et al., 2006; Kueng et al., 2006; Sutani et al., 2009); and (2)
upon proper bipolar attachment of all chromosomes, the cell will
undergo metaphase-to-anaphase transition in which the enzyme
separase cleaves the remaining centromeric cohesin rings, allowing
sister chromatid segregation to opposing spindle poles
(Waizenegger et al., 2000; Sonoda et al., 2001; Losada, 2008).
Improper attachments or lack of kinetochore tension results in
maintenance of the spindle assembly checkpoint (SAC), preventing
the metaphase-to-anaphase transition (Li and Nicklas, 1995;
Nicklas et al., 1995). Beyond the mitotic function of SCC, studies
have expanded its function to a wide assortment of cellular
functions, including DNA repair (Sjögren and Nasmyth, 2001;
Kim et al., 2002; Schar et al., 2004; Strom and Sjogren, 2005; Gause
et al., 2008; Göndör and Ohlsson, 2008; Heidinger-Pauli et al.,
2009; Covo et al., 2010; Lu et al., 2010; Dorsett and Ström, 2012),
gene regulation (Horsfield et al., 2007, 2012; Pauli et al., 2010;
Dorsett and Ström, 2012), ribogenesis (Xu et al., 2013) and
centrosome duplication (Schöckel et al., 2011; Yamada et al., 2012).
Traditionally, SCC is studied in the context of individual cells.
However, the recent discovery that components of SCC are
responsible for human developmental disorders and tumorigenesis
has illuminated the requirement for in vivo analysis (Duijf and
Benezra, 2013; Liu and Krantz, 2008). Roberts syndrome (RBS) is
caused by recessive mutations exclusively in ESCO2. Severity of
disease varies between affected individuals, from prenatal lethal to
viable beyond 30 years of age, and there is also a variety of specific
developmental phenotypes, including microcephaly, craniofacial
defects, mental retardation, limb deformities and growth retardation
(Schüle et al., 2005; Vega et al., 2010). In addition to these hallmark
phenotypes, some individuals with RBS also display cardiac defects
and corneal opacity, as well as other less prominent phenotypes
(Vega et al., 2010). Interestingly, among the few individuals that
live beyond 30, some develop tumors at an early age, suggesting a
cancer predisposition (Wenger et al., 1988; Ogilvy et al., 1993;
Schüle et al., 2005). Metaphase spreads from RBS patients displayReceived 10 November 2014; Accepted 29 May 2015
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centromeric separation and low levels of aneuploidy, suggesting
that the defects are associated with SCC and mis-segregation of
chromosomes (German, 1979; Tomkins et al., 1979). How such an
essential gene could have developmental phenotypes is unclear.
There are two vertebrate paralogs (ESCO1 and ESCO2) of the yeast
ECO1 required for establishing SCC (Skibbens et al., 1999; Toth
et al., 1999). Both ESCO1 and ESCO2 contain acetyl-transferase
domains and have the ability to acetylate SMC3, locking it in the
cohesion position. Although they seem to have overlapping
activities, the Zou lab demonstrated that they have non-redundant
functions because both must be depleted to have complete SCC loss
in HeLa cells (Hou and Zou, 2005). Potentially, the tissue-specific
phenotypes (e.g. limb, craniofacial, neural, etc.) found in
individuals with RBS (exclusively due to ESCO2 mutations) are
associated with differential requirements for ESCO1 or ESCO2 in
different tissues. In addition to RBS, there are other developmental
syndromes caused by mutations in SCC components: (1) Cornelia
de Lange syndrome (CdLS), caused bymutations in NIPBL, SMC1,
SMC3, HDAC8 and RAD21 (Krantz et al., 2004; Tonkin et al.,
2004; Musio et al., 2006; Deardorff et al., 2007; Liu and Krantz,
2008); (2) Warsaw breakage syndrome (WABS), caused by
mutations in DDX11 (van der Lelij et al., 2010; Capo-Chichi
et al., 2013); and (3) chronic atrial and intestinal dysrhythmia
(CAID), caused by mutations in SGOL1 (Chetaille et al., 2014).
Importantly, with the exception of CdLS, these syndromes all
display premature chromatid separation in metaphase spreads,
suggesting that this process is pathogenic in the diseases.
In the wake of identifying the causal gene for RBS, a few animal
models provided key initial studies for the role of ESCO2 in RBS.
The mouse knockout of Esco2 is eight-cell-stage lethal, which
unfortunately limits in vivo multicellular analysis (Whelan et al.,
2012). Utilizing a conditional allele, Esco2-null mouse embryonic
fibroblasts were generated, and cell culture analysis revealed partial
chromatid separation and genomic instability. A zebrafish morphant
(morpholino-derived partial knockdown) study focusing largely on
RBS phenotypes indicated that zebrafish can recapitulate many of
the morphological RBS-like phenotypes (Mönnich et al., 2011).
Importantly, they observed that different RBS phenotypes occurred
at varying levels of morpholino knockdown, suggesting that the
degree of SCC loss correlates with the severity of RBS phenotypes.
Notably, they describe that the mitotic and apoptotic phenotypes
associated with induction of stress genes, but not cohesin-dependent
gene expression changes, drive the RBS phenotypes. Although
these studies focus on key RBS phenotypes, little knowledge is
known about the in vivo, cellular events that result from Esco2 loss.
In this study, we characterize the dynamic, in vivo, cellular
consequences that present in an esco2 mutant zebrafish. We find
that, in addition to prolonged mitotic arrest, there are chromosome
segregation defects, micronuclei formation and genomic instability.
In addition, we demonstrate a cohesion compensatory mechanism in
a portion of cells of an esco2 mutant embryo, supporting the idea
that different cells, and potentially tissues, have different
sensitivities (or redundancies) to Esco2 loss.
RESULTS
esco2 retroviral insertionmutant identified through a unique
p53 genetic screen
During tumorigenesis, p53 is activated following cellular stress,
resulting in sequestration or termination of the stressed cell (Junttila
and Evan, 2009; Meek, 2009). Through our previous studies, we
observed that, either following loss of mdm2, the negative regulator
of p53, or following ionizing radiation (IR) treatment, zebrafish
embryos displayed a darkening of the head region, referred to as
head necrosis at 24 hpf (hours post-fertilization), which results from
an increase in apoptosis in the neural tube (Berghmans et al., 2005;
Sidi et al., 2008; Parant et al., 2010; Toruno et al., 2014). To better
understand (1) which cellular stresses activate p53, (2) what birth
defects result from p53 activation and (3) the mechanisms of p53
activation following the cellular stress, we devised a genetic screen
to identify p53-dependent embryonic-lethal zebrafish mutants.
More specifically, this screen was designed to identify embryonic-
lethal mutants with head necrosis that can be fully or partially
rescued by loss of p53. We utilized the Hopkins retroviral insertion-
derived embryonic-lethal mutant collection as a source of
embryonic-lethal mutants (Fig. 1A) (Amsterdam et al., 2004).
From this collection, we selected 90 embryonic-lethal mutants with
the head necrosis phenotype. To determine whether the head
necrosis is p53-dependent, we injected half of the clutch from 60
heterozygous intercrossed mutant families with a p53-knockdown
morpholino. Injected and uninjected embryos were monitored for
head necrosis and other morphological phenotypes between 20 and
TRANSLATIONAL IMPACT
Clinical issue
Defects in sister chromatid cohesion (SCC; the process in which sister
chromatids are paired during the cell cycle) can lead to multiple human
disorders, including but not limited to infertility, birth defects and cancer.
Although we know much about SCC in the context of individual cells, the
identification of Roberts syndrome (RBS), a developmental disorder
caused by mutations in the cohesion establishment gene ESCO2,
implies that further in vivo studies on SCC are required to understand the
disease pathology. Moreover, the unique variety of phenotypes and wide
range of severity of the disease suggest that there are differences in
cellular response and potential complex genetic interactions that are
presently not understood.
Results
This studydescribes the first characterization of anesco2mutant zebrafish
and develops the use of fluorescence single-cell time-lapse confocal
imaging to monitor the dynamics of chromosome movements during
mitosis in live zebrafish embryos. Loss of Esco2 results in embryonic
lethality due to extensive chromosome scattering upon entrance into
prometaphase, in a prolonged mitotic delay and, ultimately, in imprecise
chromosome segregation upon division. Various forms of genomic
instability result from these divisions, including the development of
micronuclei and anaphase bridges, which activate a neural-tube-specific
p53-dependent apoptotic response inearly development.Most noteworthy
is that some cells divide with normal mitotic progression and lack genomic
instability in the esco2 mutant, which suggests that compensatory
cohesion establishment mechanisms are in place to allow for normal
mitotic progression and division in these cells.
Implications and future directions
This work exemplifies the novelty of observing the dynamics of cell
divisions in a live vertebrate organism. It also suggests, for the first time,
that compensatory mechanisms might influence the spectrum of
phenotypes observed in RBS. Further studies will investigate tissue-
specific differences, identify the compensatory mechanisms and
visualize the dynamics that regulate such mechanisms. Globally, this
research will impact not only developmental disorders but also infertility
and tumorigenesis. Somatic mutations have been found in a multitude of
cancer types, and key defects in SCC have been associated with
increased tumorigenesis. Female, and most recently male, infertility has
also been shown to be caused by defects in SCC, further supporting the
importance of understanding how SCC is regulated. By identifying key
compensatory mechanisms, these could be exploited as therapeutic
targets for treating SCC-associated human diseases.
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48 hpf. From this primary screen, we identified ten mutants that
displayed partial rescue following p53 morpholino injection
(hi821a, hi1045, hi1477, hi2404, hi2877b, hi2865, hi2975,
hi3635, hi3662, hi3820a). None of the ten mutants displayed
complete rescue following p53 morpholino injections, suggesting
either that additional non-p53-dependent defects are present or that
the morpholino knockdown was not complete or was no longer
effective at inhibiting p53 activity over time.
One of the mutants identified was the hi2865 line, with a
retroviral insertion in intron 1 of the ENDARG00000014685 gene
(Fig. 1B; supplementary material Fig. S1A). To determine whether
homozygosity for this insertion correlated with the mutant
phenotype observed, we performed high-resolution melt curve
analysis (HRMA), in addition to multiplex allele-specific PCR
(supplementary material Fig. S1B and C, respectively). The results
confirmed that 100% (n=11 of 11) of mutant embryos were
homozygous for the insertion, and that none (n=32 of 32) of
the normal siblings were homozygous for the insertion.
ENDARG00000014685 has homology to the establishment of
cohesion homolog 2 gene (ESCO2), and displays strong synteny
with the mouse and human genomic region surrounding ESCO2
(supplementary material Fig. S1D).
Previous work has shown that the majority of intron 1 retroviral
insertions knock down the endogenous gene transcript by greater
than 80% (Wang et al., 2007). We performed qRT-PCR on pooled
wild-type (WT) and mutant embryos (henceforth esco2hi2865/hi2865
will be referred to as esco2m/m) at 18 hpf, 30 hpf and 48 hpf. By
18 hpf, we observed ∼7% of normal transcript and by 48 hpf ∼2%
of transcript (supplementary material Fig. S2), indicating: (1) the
retroviral insertion diminished the esco2 transcript by >95%, and (2)
by 18 hpf, the majority of maternal transcript is absent. To further
validate that these morphological phenotypes are due to disruption
of esco2, we have recently generated an esco2 exon 3 frameshift
mutation (esco2+13), using the CRISPR genome-editing system
(Hwang et al., 2013; Jao et al., 2013; Thomas et al., 2014).
Homozygous esco2+13/+13 embryos have the same gross
morphological phenotypes (supplementary material Fig. S3A,B)
and decrease in esco2 mRNA expression (supplementary material
Fig. S2) as esco2m/m embryos. Note that the reduced mRNA
expression in the esco2+13/+13 embryos is most likely due to
Fig. 1. Genetic screen identifies the
retroviral insertion embryonic lethal
mutant, hi2865. (A) Design of the screen
used to identify insertion mutants
exhibiting microcephaly and head
necrosis, amongst 350 embryonic lethal
(EL) mutants, that are rescued by
morpholino (MO) knockdown of p53
(numbers in parentheses indicate the
number of mutants at each stage) at
24 hpf. (B) Brightfield images of a 24-hpf
hi2865 sibling and homozygous mutant
(henceforth esco2hi2865/hi2865 will be
referred to as esco2m/m) embryos injected
or uninjected with p53 MO. (C) esco2+/+,
esco2m/m and esco2m/m; p53dzy7/dzy7
(henceforth p53dzy7/dzy7 will be referred to
as p53m/m) gross morphological
phenotypes between 30 hpf and 102 hpf
(4 dpf). (D) Head measurements and
(E) embryo area of esco2+/+, esco2m/m,
esco2+/+; p53−/− and esco2m/m; p53−/−
were measured using ImageJ in arbitrary
units (n=5/genotype, mean±s.d., *P<0.05,
**P<0.01, ***P<0.001; significance values
shown below the red line are derived from
comparing esco2m/m versus esco2+/+;
significance values shown below the
purple line are from comparing esco2m/m;
p53m/m versus esco2m/m). Insets in each
graph depict the measurement
parameters highlighted in red. (F,G) DIC
images depict fin and heart defects,
respectively, in esco2m/m. Insets detail
normal fin and remnant fin bud. Scale
bars: 50 µm.
943
RESEARCH ARTICLE Disease Models & Mechanisms (2015) 8, 941-955 doi:10.1242/dmm.019059
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
nonsense-mediated decay due to the premature stop in the +13
transcript.
esco2 deficiency has many severe RBS-like phenotypes
We wanted to determine whether our esco2mutant animal modeled
the human RBS patient phenotypes. Although there are strong
variations in the RBS phenotypes, individuals with prenatal-lethal
RBS consistently have microcephaly, growth retardation,
craniofacial defects and limb deformities (Schüle et al., 2005).
Gross morphology at 30 hpf of the esco2m/m (Amsterdam et al.,
2004) zebrafish showed head necrosis and growth retardation
(Fig. 1C). At 48 hpf, the head size was reduced dramatically
compared to the WT. Importantly, head and gross embryo size
measurements suggest a lackof growth compared toWT (Fig. 1D,E),
reminiscent of human microcephaly and growth retardation.
Furthermore, in WT embryos at 48 hpf, the early embryonic
pectoral fin (analogous to the forelimb in mammals) had formed;
however, the fin was absent in the majority of mutants (seven out of
ten), and only a small nub in the other mutant embryos (Fig. 1F),
indicating defects in limb formation. Unfortunately, by 4 days post-
fertilization (dpf) all esco2m/m embryos (n=20) were almost
completely degraded (Fig. 1C), obscuring the ability to address
craniofacial abnormalities because craniofacial bone/cartilage does
not begin to appear until 5 dpf. Although not a hallmark of RBS,
heart defects are prevalent in 25-75% of patients (Vega et al., 2010).
We observed that, although the majority of esco2 mutant embryos
seem to undergo proper morphogenesis (formation of an atrium and
ventricle) and have 1:1 atrioventricular (A-V) contractions, they do
not undergo proper heart looping and often have variable heartbeat
rates and lack of blood flow (Fig. 1G; supplementary material
Movies 1 and 2). Whereas the phenotype of RBS patients is quite
pleiotropic (presumed to be due to genetic diversity), the zebrafish
phenotypes are very consistent and most likely reflect nearly
isogenic backgrounds of our zebrafish.
p53 activation and neural tube apoptosis is an early
consequence of loss of Esco2
Initially, we identified this mutant by the ability of a p53
morpholino to partially rescue the gross morphological
phenotypes. To biochemically confirm p53 activation, we probed
protein extracts from controls (AB strain), esco2 mutant and esco2
sibling embryos for p53. We observed that p53 stabilization was
strong in esco2m/m embryos (179-fold at 30 hpf) but not in WT
controls (Fig. 2A). To determine whether genetic loss of p53 could
rescue our esco2m/m phenotypes, we generated esco2hi2865/hi2865;
p53dzy7/dzy7 mutant embryos (henceforth referred to as esco2m/m;
p53m/m), in which the dzy7 allele has an I166T mutation in the
DNA-binding domain of p53, rendering it transcriptionally inactive
(Parant et al., 2010). In contrast to the prominent head necrosis
phenotype observed in esco2m/m alone, esco2m/m; p53m/m showed
severely diminished head necrosis (Fig. 1C) with stabilization of the
p53 mutant protein (Fig. 2A). As observed by gross morphology,
our quantitative measurements of microcephaly and growth
retardation indicate a partial rescue of these phenotypes (Fig. 1D,E).
One of the major outcomes of p53 activation is apoptosis.
Therefore, to further understand the esco2 mutant phenotype, we
stained esco2+/+ and esco2m/m embryos for apoptosis at 18, 24, 30,
48 and 72 hpf using the live apoptotic dye acridine orange.
Interestingly, we observed that, at 18, 24 and 30 hpf, esco2m/m
embryos had increased levels of apoptosis with a higher proportion
of apoptosis predominantly in the neural tube at 24 and 30 hpf
(Fig. 2B,C). Interestingly, this increase in neural tube apoptosis is
consistent with our previously described increase in neural tube
apoptosis following IR treatment (Fig. 2C). By 48 hpf and later,
apoptosis was no longer observed in the mutant embryos,
suggesting that the sensitivity to stress-inducing apoptosis or the
stress no longer present in these cells, or that all of the cells sensitive
to the stress have died. At 18 hpf in the p53 mutant background, we
observed an absence of apoptosis in esco2m/m; p53m/m embryos;
however, by 30 hpf we observed a similar level of apoptosis within
the esco2m/m; p53m/m embryos as the esco2m/m embryos (Fig. 2C).
This suggests that the initial consequence of Esco2 loss results in
p53-induced apoptosis. However, a subsequent stress-induced
apoptosis occurs in the absence of p53. This is also reminiscent
of irradiation experiments in the p53 mutant embryo, where this
initial apoptosis following IR treatment is abrogated in a p53 mutant
background but a secondary apoptosis occurs later (Parant et al.,
2010). Our interpretation is that, although p53 loss abrogates
the response, the damage or stress is still present and detrimental to
the cell.
Esco2 deficiency results in embryonic lethality associated
with chromosome scattering and increased mitotic index
SCC is required for proper mitotic progression. Toward determining
the cellular consequences that lead to this embryonic lethality,
we performed western blot as well as immunohistochemistry onWT
and mutant embryos with an anti-phosphorylated histone-H3 (pH3;
a marker of cells in M-phase of the cell cycle) antibody.
A significant increase in the number of pH3-positive cells (2.3-
fold; Fig. 3A,B) and total pH3 protein (8.3-fold; Fig. 3C) was
observed in esco2m/m compared to WT embryos, suggesting that
mutant embryos undergo mitotic arrest.
To determine at which phase of mitosis pH3-positive cells were
accumulating, we generated mitotic-phase profiles of AB, esco2+/+
and esco2m/m embryos. These were immunolabeled with pH3 and
observed under confocal imaging. Four independent fields were
imaged through the entire embryo to capture all cells in mitosis in a
given field (Fig. 3D). Based on pH3 morphology, the phase of
mitosis was determined for each pH3-positive cell and quantified
for each genotype (Fig. 3E,F). Although all genotypes displayed
the five distinctive mitotic phases (prophase, prometaphase,
metaphase, anaphase and telophase), the esco2m/m embryos also
displayed a unique scattered chromosome morphology (Fig. 3E,F).
Although AB and esco2+/+ profiles were comparable, the esco2m/m
embryos had a significant increase in the number of scattered
chromosome-containing cells (Fig. 3F). Within mutants, 60% of
pH3-positive cells had the scattered morphology, which accounts
for the increase in the total number of pH3-positive cells (Fig. 3B).
These data suggest that the scattered phenotype results in a mitotic
arrest leading to the early lethality in the esco2m/m. Furthermore, we
did not observe a difference in the presence of scattered phenotype
or the mitotic profile in a p53 mutant background (supplementary
material Fig. S4), suggesting that, although p53 responds to this
defect and loss of p53 temporarily abrogates the apoptotic response,
it does not influence or rescue the actual mitotic defects in the esco2
mutant embryos.
Dynamic, in-embryo analysis of chromosome segregation
reveals detailed consequences of Esco2 loss
The static analysis of mitosis thus far indicates that many cells in the
esco2m/m embryos undergo a mitotic arrest with a scattered
chromosome phenotype and suggests that this extended mitotic
arrest leads to cell death during mitosis. To obtain a more dynamic
analysis under physiological conditions, we have developed a novel
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technique to monitor chromosome segregation at the single-cell
level within a live zebrafish embryo. One-cell-staged embryos are
injected with mRNA encoding H2afva-GFP (labels chromatin) and
CaaX-mCherry (labels plasma membrane). At 24 hpf, embryos are
placed in a coverslip-bottom dish and imaged using time-lapse
confocal microscopy (Fig. 4A).
With this approach, we demonstrate that AB and esco2+/+ embryos
undergo normal progression through mitosis (Fig. 4B) with an
average division time – from nuclear envelope breakdown (NEB) to
nuclear envelope reformation (NER) in the two daughter cells – of
21 min (Fig. 4C; supplementary material Movie 3). However, cells
from esco2m/m embryos undergo a rapid progression to the scattered
chromosome phenotype following NEB (Fig. 4D; supplementary
material Movie 4) and never form a proper metaphase plate. Upon
chromosome scattering, the entire chromatin material proceeds to
rotate within the cell for a prolonged period of time (Fig. 4D). To our
surprise, the cells with scattered chromosomes do eventually divide
with an average division time of 80 min (Fig. 4C). The longest
completemitosis fromNEB toNERobserved for a cell with scattered
morphology was 2 h; however, a number of scattered cells persisted
beyond the 4-h time-lapse recordings. This analysis suggests that loss
of Esco2 results in chromosome scattering following NEB, which
Fig. 2. p53 activation and neural tube apoptosis is an early consequence of loss of esco2. (A) Western blot for p53 protein levels in protein extracts from AB
(esco2+/+), esco2 sib (esco2+/+ and esco2+/m), esco2 mutant (esco2m/m), esco2sib; p53m/m and esco2m/m; p53m/m embryos at 18 and 30 hpf. Irradiated (IR)
embryos at 100 Gy were used as a positive control. Relative intensities were determined using ImageJ; each sample was normalized to GAPDH intensity,
and then relative expression was calculated against esco2+/+ (relative normalized intensity=1). (B) Fluorescent and DIC/fluorescent merge images of esco2+/+
and esco2m/m 24-hpf embryos stainedwith acridine orange. (C) Acridine orange time-course staining spatially displaying apoptotic cells in esco2+/+, esco2m/m and
esco2m/m; p53m/m. AB embryos irradiated at 24 hpf were used as a positive control for DNA-damage-induced neural tube apoptosis. Insets depict higher
magnification to visualize neural tube apoptosis.
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induces a prolongedmitotic delay most likely due to failure to satisfy
the spindle assembly checkpoint.
From the in vivo imaging of embryos, we did not observe the
formation of apoptotic bodies during mitosis; however, we did
observe apoptosis occurring within interphase cells (supplementary
material Movie 5). This suggests that the apoptotic event occurs
after mitotic exit, potentially in G1, in which p53 has been strongly
associated with an apoptotic response (Yonish-Rouach et al., 1993).
Loss of Esco2 results in genomic instability
We observed, through in-embryo, time-lapse imaging, that, upon
division, multiple in vivo segregation defects occur. Whereas,
amongst WT embryos (three embryos, 11 divisions monitored), no
erroneous divisions were observed, among 43 mutant divisions
monitored from four different embryos, on average: 37% (±9% s.d.)
of the divisions per embryo had lagging chromosomes [66%
(n=10/15) involved one sister chromatid; 13% (n=2/15) involved
two sister chromatids; 7% (n=1/15) involved three sister chromatids;
13% (n=2/15) involved 4+ sister chromatids] that developed
into micronuclei [MN; Fig. 5A,B; supplementary material
Movie 6; 85% (n=11/13) of cell divisions result in forming just
one MN and 15% (n=2/13) of cell divisions result in two MN being
formed]; 29% (±7% s.d.) of divisions per embryo had chromosomes
decondense prior to cytokinesis, resulting in anaphase bridges
during cytokinesis (Fig. 5A,B; supplementary material Movie 7);
and 13% (±13% s.d.) of divisions per embryo had the chromosomes
decondensewithout cytokinesis (Fig. 5A,B; supplementarymaterial
Movie 8) reminiscent of endoreduplication. We observed a
significant increase in phosphorylated-H2AX (γ-H2AX) in
mutants compared to AB or WT sibling controls (Fig. 5C),
suggesting that chromosome-segregation abnormalities induce a
DNA damage response. Interestingly, we observed that eight of the
43 (21%) divisions in esco2m/m embryos underwent what appears to
be normal ‘without error’ mitotic divisions (Fig. 5A,B;
supplementary material Movie 9).
To further address the consequence of these imprecise divisions,
we analyzed our metaphase spreads from AB control and
homozygous mutant embryos for the number of chromatids
present. Zebrafish have 25 chromosomes and therefore 100 sister
chromatids per metaphase cell. Most striking was that the majority
(92%) of spreads from esco2m/m embryos did not have 100
chromatids (Fig. 5D). In fact, there was a bias toward loss of
chromatids (73% loss versus 19% gained), suggesting that either the
cells with micronuclei or the chromosome(s) contained in the
micronuclei are eliminated. The reduction in the number of
micronuclei in interphase cells (Fig. 5E), and our observation of a
micronuclei-containing cell undergoing apoptosis (supplementary
material Movie 5), further support the elimination of cells containing
micronuclei. The chromosome numbers in esco2m/m ranged from loss
of 25 chromatids to gain of ten chromatids (Fig. 5D). Because
Fig. 3. esco2 deficiency results in an elevated mitotic index and scattered chromosomes. (A) Maximum intensity projections of whole-embryo confocal
z-stack images of pH3-stained fixed WT and mutant embryos. The embryo proper is outlined by the white dotted line. Yolk has been removed for imaging.
(B) Quantification of the number of pH3-positive cells per embryo in A (n=3/genotype, mean±s.d., **P<0.01). (C) Western blot analysis for pH3 protein levels from
esco2+/+ (AB), esco2 sibling (+/+ and m/+) and esco2mutant (m/m) embryo protein lysates. Relative intensity calculated using ImageJ; each samplewas normalized
to α-tubulin intensity, and then relative expression was calculated against esco2+/+ (relative normalized intensity=1). (D) Diagram of mitotic profiling. Four
independent fields of a pH3-labeled embryo are imaged, compiled using maximum intensity projection, and scored for each phase of mitosis based on
chromosome morphology. (E) Colored panels depict the associated pH3 morphology to its phase in mitosis. (F) Graph depicting the percentage of cells in each
phase of mitosis between AB (the WT parental strain) controls, esco2+/+ and esco2m/m embryos (four fields/embryo, n≥70 morphologies per embryo, three
embryos/genotype, mean±s.d.); the P-value of scattered between esco2+/+ and esco2m/m is 0.0062.
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the majority of mis-segregation results in one mis-segregated
chromosome per division, this suggests that the large range of
chromatid numbers was the consequence of multiple defective
divisions. These data suggest that it is not the aneuploidy (the change
in chromosome number), but the micronuclei formation that is
deleterious to a cell.
Esco2 is required for cohesion establishment; however,
compensatory cohesion mechanisms within some cells
restore timely divisions andproperchromosomesegregation
in esco2mutant embryos
Both esco1 and esco2 (two homologs of yeast eco1) are responsible
for establishing cohesion; thus, we wanted to determine whether loss
of esco2 alone would have an effect on cohesion between
sister chromatids. Therefore, we generated metaphase spreads and
observed three categories of metaphase spreads in WT and mutant
embryos: (1) ‘paired’, SCC within the arms and the centromere;
(2) ‘paired but separated’ (PBS) phenotype, in which the centromeres
are separated but the sister chromatids still neighboreachother; and (3)
‘separated’, where sister chromatids are not cohered in the arms or
centromere and appear as single chromatids (Fig. 6A). Although
100% of esco2+/+ controls had the classic paired cohesion
morphology, 85% of the esco2m/m spreads yielded a separated
morphology, suggesting complete loss of cohesion in the absence of
Esco2 and that the scattered phenotype is largely due to lack of
cohesion between chromatids.
Interestingly, although the majority of esco2 mutant spreads had
complete chromatid separation, 15% of spreads yielded a PBS
morphology. These data propose that there is only reduced cohesion
within these cells and that alternative cohesion mechanisms exist to
Fig. 4. In vivo analysis of esco2 mutants reveals chromosome scattering and a prolonged division time. (A) Schematic of in-embryo confocal imaging.
Embryos are injected at the one-cell stage, embedded in low-melt agarose at 24 hpf in a coverslip-bottom dish, and visualized with confocal imaging focusing
on the thinner tail region. (B) Stills extracted from time-lapse imaging videos of wild-type embryos emphasizing phases of mitosis beginning at prophase and
ending at the formation of two daughter cells. Time stamps are in minutes. (C) Division time of AB, esco2+/+ and esco2m/m calculated from nuclear envelope
breakdown (NEB) to division into two daughter cells in minutes (mean±s.d., **P<0.01 derived from comparing m/m to either AB or +/+). (D) Time-lapse imaging
stills extracted from videos depict esco2 mutant’s mitotic entry, spindle rotation and scattering, and mitotic exit resulting in micronuclei formation (arrowhead).
Arrows point towards the cell of interest. Curved arrows orient to the direction of spinning. Time stamps are in minutes.
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compensate for the loss of Esco2 in these cells. Alternatively, although
the analysis of maternal esco2 mRNA suggests that maternal
transcripts are absent by 18 hpf (supplementary material Fig. S2) and
published data indicate that the Esco2 protein is degraded during
metaphase (therefore degrading maternal protein in early divisions)
(Hou andZou, 2005), there is the potential that, at 24 hpf, these 15%of
cells with the PBS phenotype have a remnant of maternal esco2.
Therefore, to determine whether this phenotype persists beyond
normal maternal contributions, we have analyzed the amount of PBS
spreads at 24, 48 and72 hpf.Although the numberof separated spreads
decreases over time, presumably due to cell death or cellular arrest, the
number of PBS cells increased (Fig. 6B).
To determine whether the PBS cells maintain a different ploidy,
we analyzed chromatid number from separated and PBS spreads
from esco2 mutant embryos. The majority of spreads (92%) with
‘separated’ chromatids had improper ploidy (Fig. 6C). Remarkably,
the sister chromatids that are partially separated in PBS spreads still
achieve proper ploidy in 47% of PBS mitotic spreads, whereas 53%
show only mild aneuploidy (Fig. 6C; ranging from ±4 chromatids).
This would suggest that the spreads with proper ploidy in Fig. 5D
are mostly the PBS cells. The high percentage of normal ploidy
spreads (47%) suggests that multiple precise divisions must have
occurred in these PBS cells. Therefore, mild separation does not
seem to impinge greatly on microtubule attachment and segregation
of sister chromatids at the metaphase-anaphase transition. These
observations suggest that there are two pools of mutant cells: (1)
cells with complete cohesion loss, separated chromatids, and high
aneuploidy biasing toward loss of chromatids; and (2) weakened
Fig. 5. Depletion of esco2 results in genomic instability. (A) Stills taken from time-lapse imaging videos demonstrating the variety of genomic instability
observed in 24-hpf esco2 mutant embryos. Micronuclei, anaphase bridges and failed cytokinesis were observed, as well as ‘without error’ divisions. Arrowhead
points towards micronuclei. Arrow points to an anaphase bridge. Time stamps are in minutes. (B) Average frequency of above division fates in wild-type
(11 divisions taken from three embryos) and esco2 mutant (43 divisions from four embryos) embryos based on time-lapse imaging. Error bars show mean±s.d.
between embryos. All wild-type cells underwent a normal division; therefore, there is no s.d. or error bar to report. (C) Western blot of γ-H2AX in protein lysates
from 24-hpf esco2+/+ (AB), esco2 sib (+/+ and +/m) and esco2m/m embryos. Irradiated (IR) embryos (100 Gy at 24 hpf and collected at 30 hpf) serve as a positive
control. Relative intensity was calculated using ImageJ; each sample was normalized to α-tubulin intensity, and then relative expression was calculated
against esco2+/+ (relative normalized intensity=1). (D) Quantification of the number of chromatids within metaphase spreads (n≥20 spreads per genotype) from
pooled (10-12 embryos) esco2+/+ (AB controls) and esco2m/m embryos. (E) Frequency of micronuclei observed in interphase cells of the tail region of embryos
injected with H2afva-eGFP; CAAX-mCherry mRNA. Percentage is based on total number of micronuclei observed over the number of nuclei observed in
interphase cells (n=3 embryos/genotype, >75 cells per field, mean±s.d., *P<0.05).
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cohesion, PBS chromatids, and none to mild aneuploidy with
equivalent gains and losses.
The presence of proper ploidy subsequently led us to hypothesize
that the ‘without errors’ divisions that are present in ∼20% of esco2
mutant cells (Fig. 5B) represents those cells that displayed the PBS
phenotype in chromosome spreads. To determine whether there
were differences in the division timing of these two populations of
cells, we measured the timing from NEB to NER in 56 mitotic
Fig. 6. Most cells of the esco2m/m embryo display complete cohesion loss, although some cells display mild cohesion defects, mild aneuploidy and
almost normal mitotic transition. (A-C) Metaphase chromosome spreads from pooled (10-12 embryos) esco2+/+ (AB) and esco2m/m embryos display three
key categories: ‘paired’, ‘paired but separated’ (PBS) and ‘separated’. (A) Percentage distribution of spread categories (n≥20 spreads/genotype) from pooled
esco2+/+ and esco2m/m 24-hpf embryos. Insets in chromosome spreads are higher-magnified versions of the observed categories. If mixed categories were
observed in the same spreads, theywere counted toward the category in which themost prevalent phenotypewas observed. (B) Frequency of PBS and separated
spread categories from pooled esco2m/m at 24, 48 and 72 hpf (n≥20 spreads/time-point). (C) Frequency of chromatid number within a spread categorized to be
either the ‘paired but separated’ (PBS) or ‘separated’ phenotype from 24-hpf pooled esco2m/m mutants. Chart also contains frequency of chromatid number
from esco2+/+ as a control. (D) Division time from NEB to NER of cells from esco2+/+ embryos, or cells divisions deemed ‘without error’ from esco2m/m embryo
time-lapse videos.
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divisions in esco2mutant embryos using our in-embryo, time-lapse
technique (Fig. 2A), with a 2-min interval between stacks over 2 h.
The majority (73%) of divisions either: (1) underwent NEB but not
NER, (2) were in the midst of dividing at the start of time-lapse, or
(3) were in mitosis for the entire 2-h time-lapse. Because these were
not complete divisions, accurate division times could not be
determined and therefore were not included in this analysis.
Complete divisions were segregated based on two categories: (1)
those that display ‘genomic instability’ or (2) those that display
division ‘without error’. Consistent with our previous observation
on cell fates (20% in Fig. 5A,B), 14% (8 of 56) of the total amount
of mitotic cells were ‘without error’. Importantly, 50% (4 of 8) of
‘without error’ cells underwent a comparable division time to WT
cells (t=26.5 or 25.1 min, respectively), whereas the other 50% of
‘without error’ had an average division time of 47 min, twice the
division time of esco2 WT cells (Fig. 6D). We suggest that these
divisions, although they undergo no evidence of genomic instability
through live imaging, are delayed in satisfying the SAC. Although
biased because it does not include the scattered genomic-instability-
prone divisions that last the entire video time (15 of 56 divisions),
the average division time for ‘genomic instability’ divisions was
92.8 min, much longer than the ‘without error’ divisions. Overall,
these data suggest that, in an esco2 mutant, a weakened cohesion
phenotype exists in a subset of cells and that these cells divide with
normal mitotic progression and ploidy.
DISCUSSION
At the molecular level, our data indicates that, in the majority of
cells, deficiency of esco2 results in complete cohesion loss,
genomic instability, aneuploidy and/or micronuclei formation that
activates a DNA damage response that includes p53 (Fig. 7A). Our
time-lapse imaging revealed that some cells containing micronuclei
undergo apoptosis. Recent studies have demonstrated that
micronuclei undergo late replication and induce a DNA damage
response (γ-H2AX), which, in the absence of p53, can result in a
chromothripsis phenomenon (Crasta et al., 2012). Our data is
consistent with this, in that we observed micronuclei and γ-H2AX
staining; however, in our mutants we also observed an apoptotic
response that most likely reflects the presence of a functional p53.
This suggests that it is the micronuclei, not aneuploidy, that is
inducing a p53 response. It should be noted that, although we have
focused on a lagging chromosome-micronuclei model (Fig. 7A), we
have not truly addressed the amount of aneuploidy derived from the
prematurely segregated chromosomes. Interestingly, our data
(Fig. 6B) indicates that compensated cells (PBS) accumulate over
time, whereas the number of cells with the ‘separated’ phenotype is
reduced. This suggests that the ‘separated’/scattered cells undergo
apoptosis, leaving a selective advantage of the PBS/compensated
cell. Importantly, although p53 activation is a response to genomic
instability, it does not correct the genomic instability, which
ultimately cannot be tolerated by the organism; hence, there is only
partial rescue of RBS phenotypes. With this in mind, we feel that
therapies aimed at suppressing the stress response will only delay
the defects considering that the stress is still present. Alternatively,
the fact that we observe compensation in some cells, in addition to
the genetic background influences on the severity of RBS in
humans, suggests that, if we can restore cohesion, we can remedy
many of the RBS phenotypes. Therefore, understanding the
contribution that the genes in the cohesion network have on SCC
in vivo becomes important.
We observed that the genomic-instability-induced apoptosis
occurs predominantly in the neural tube. These results are consistent
with other published data on DNA-damage-induced genomic
instability in mouse and zebrafish (Lang et al., 2004; Berghmans
et al., 2005; Sidi et al., 2008; Parant et al., 2010; Toruno et al.,
2014). These tissue-specific effects might explain the many neural-
related RBS phenotypes such as microcephaly, craniofacial defects
and mental retardation. This observation is not unfounded in that,
during embryonic development, persistent cellular stress (often due
to inherited gene mutations that lead to cellular stress, i.e. genomic
instability) results in p53 activation and neurodevelopmental
phenotypes. Many of the neural-crest-derived craniofacial
phenotypes in the Treacher Collins syndrome mouse model are
resolved in a p53 mutant background (Jones et al., 2008). In
addition, centrosomal stress has been linked to aneuploidy resulting
in significant brain degeneration and microcephaly in a Plk4
overexpression mouse model (Marthiens et al., 2013). Studies of
mosaic variegated aneuploidy (MVA) patients harboring mutations
in Bub1b and Cep57 also showed aneuploidy and microcephaly
(Hanks et al., 2006; Snape et al., 2011). Together, this suggests that
early neuronal tissue might be more predisposed to undergo
apoptosis in response to genomic instability. In fact, the lack of
apoptosis at 48 and 72 hpf (Fig. 2C) and the morphological collapse
of the head (Fig. 1C,F,G) suggest that all of the apoptosis-
susceptible neural tube cells have died, while some scattered cells
still exist (Fig. 6B).
Prior to identification of ESCO2 as the gene responsible for RBS,
there were two disorders: as a generalization, RBS encompassed the
stillborn and early-postnatal-lethal individuals, whereas SC
phocomelia syndrome was less severe and affected individuals
often lived to childhood and even adulthood (Schüle et al., 2005).
Although the phenotypes vary between individuals, premature
chromatid separation is a hallmark among patients and was used as a
diagnostic tool. These two syndromes were united under the title
RBS upon identification that 100% of both disorders were due to
ESCO2 mutations, with no phenotype-genotype correlation
identified, suggesting that genetic background likely influences the
phenotypes (Maserati et al., 1991; Schüle et al., 2005; Vega et al.,
2010). Interestingly, in all animal models analyzed to date (yeast, fly,
zebrafish andmouse), genetic loss ofESCO2 results in early lethality
(Skibbens et al., 1999; Toth et al., 1999; Williams et al., 2003;
Whelan et al., 2012). This leaves the question, why are some human
ESCO2-null individuals viable? In fact, one individual was identified
to be ESCO2-null but displayed very mild phenotypes and therefore
escaped diagnosis until adulthood (Goh et al., 2010). On the other
side of the coin, there is the notion that humans null for ESCO2 are
not early embryonic lethal; however, there is an ascertainment bias
toward identifiable patients (stillborn fetuses, children with birth
defects and viable patients), but not embryonic lethal prior to the
second term due to lack of detection. Part of the early lethality or lack
of variable phenotypes amongst animal models can be attributed to
the isogenic/near-isogeneic nature of the models. Alternatively,
humans might have evolved compensation mechanisms, such as
potentially higher levels of ESCO1. Whereas Esco2-null mice are
early eight-cell (∼3 dpf) lethal, the zebrafish mutant proceeds
through gastrulation and early embryogenesis (<18 hpf) owing to
maternal stores of esco2mRNA. This is convenient in the sense that
RBS-like phenotypes can be observed owing to the unabated
transition through early embryogenesis. Interestingly, whereas our
esco2 mutant embryos displayed many of the severe RBS
phenotypes, the published morpholino knockdown displayed
milder RBS phenotypes, such as craniofacial defects (Mönnich
et al., 2011). The morpholino is only a partial knockdown of esco2;
therefore, this observation most likely reflects the esco2 dose effect
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on phenotypes. Whether through compensation or esco2 dose, this
lends to our hypothesis that the amount of cohesion dysfunction will
correlate with the severity of the RBS phenotypes (Fig. 7B).
Although the above example focuses on esco2, involving the large
number of SCC factors in the complex genetic network will expand
our understanding of which factors influence the amount of cohesion
dysfunction and how this network impacts the severity of disease.
The fact that we observed compensation in some cells opens up
the possibility that there are other genetic factors (maybe esco1) that
influence cohesion establishment, and these factors might have
higher expression in a subset of cells/tissues (Fig. 7B). Toward this,
we have recently generated an esco1 mutant, which has cohesion
defects as well as compensation in a subset of metaphase spreads
(S.M.P., H.R.T. and J.M.P., unpublished data). This suggests that:
(1) esco1 is also important for cohesion establishment; and (2) esco1
and esco2 might have differential cell expressions, resulting in the
variable cohesion loss. Beyond esco1 and esco2, there are a number
of cohesion establishment (e.g. ATAD5, CHTF18 and RBMX1),
maintenance (e.g. SGOL1 and sororin) and anti-establishment
factors (e.g. WAPAL, PDS5a, PDS5b and HDAC8) that might
impinge on this compensation (Bermudez et al., 2003; Lengronne
et al., 2006; Maradeo and Skibbens, 2009; Matsunaga et al., 2012).
Clinically, this observation has the potential to explain why there are
particular morphogenic phenotypes (i.e. limb deformities or
craniofacial defects) amongst a normal body plan in individuals
with RBS; some tissues might have differential compensation for
ESCO2 loss.
In closing, we have identified a zebrafish genetic mutant in esco2
that models RBS. The transparency of the zebrafish embryo has
allowed us to monitor the in vivo chromosome segregation dynamics
in real time and revealed the dynamic chromosome segregation
defects in the esco2 mutants. In addition, the future use of guide-
directed EGFP-tethered endonuclease-dead Cas9 will allow for in
vivomonitoring of the distances between sister chromatids (identified
as two EGFP spots), much like that used in yeast cohesion separation
studies (Straight et al., 1996; Michaelis et al., 1997; Chen et al.,
Fig. 7. Model depicting cellular outcomes in
esco2 mutant zebrafish embryos and
hypothesized impact that compensation might
have on RBS phenotypes. (A) A model of the
molecular and cellular event ongoing in the esco2
mutant zebrafish. The majority of cells undergo a
prolonged mitotic delay ultimately resulting in a
single chromatid mis-segregation yielding a
micronuclei. We observed: (i) through live imaging an
interphase cell with a micronuclei undergo
apoptosis, (ii) increased levels of γ-H2ax, indicating
a DNA damage response (DDR), and (iii) p53-
dependent apoptosis within the neural tube.
Together, these data suggest that the micronuclei
induce a DDR response to activate the p53 apoptotic
response. There is subsequent apoptosis even in the
absence of p53, suggesting that an alternative
apoptotic signal exists. Other cells within the esco2
mutant embryos appear to undergo a normal mitotic
progression, and have only mild cohesion loss,
suggesting that compensation mechanisms exist.
(B) Depicts a model in which variation in
compensation between individuals and between
tissues in an individual might explain the phenotypic
differences between individuals with RBS.
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2013). Applied to the esco2 mutant embryos, this technique will
help to spatially identify which cells have PBS and which are
completely separated, in addition to determining the long-term
consequence of these phenotypes. Furthermore, the ability of some
cells to compensate for Esco2 loss suggests differential cohesion
dysfunction between cells or tissues and might explain the specific
RBS phenotypes. Importantly, understanding this compensation
network has therapeutic application if cohesion can be restored in
RBS patients and in individuals with other cohesion-driven diseases.
MATERIALS AND METHODS
Zebrafish lines
All zebrafish lines were maintained as described inWesterfield (1995) under
standard laboratory conditions (Westerfield, 1995). AB WT zebrafish were
used for morpholino injections and controls. The esco2 retroviral insertion
allele was obtained from Nancy Hopkins and Jacqueline A. Lees
(Massachusetts Institute of Technology, Cambridge, MA) and maintained
on the AB background.
Genotyping
High resolution melt curve analysis (HRMA)
Individual embryos or tail clippings were placed in 100 µl ELB (10 mMTris
pH 8.3, 50 mM KCl, 0.3% Tween 20, 0.3% NP40, 1 mg/ml Proteinase K)
in 96-well plates. Embryos/tail clips were incubated at 55°C for 4 h
to overnight, depending on sample size, to generate genomic DNA.
To inactivate Proteinase K, plates were incubated at 95°C for 10 min. For
esco2 hi2865 genotyping, PCR fragments were generated using primer V:
5′-TTTCACTGTTTCTGCAGGTTG-3′ and X: 5′-TAAGGTCTTCGAA-
GTCTTAACG-3′ to amplify WT products. Primers V: 5′-TTTCACTGT-
TTCTGCAGGTTG-3′ and W: 5′-GGGGGGGGGCCTACAGGTGGGG-
TCTTTC-3′ were used to amplify the viral insertion product. PCR reactions
were performed using genomic DNA in black/white 96-well plates
(Bio-Rad cat. no. HSP9665). PCR reaction protocol for retroviral
insertion detection was 95°C for 20 s, then 40 cycles of 95°C for 10 s,
59°C for 20 s and 72°C for 8 s in Eppendorf Mastercycler Pro 96S.
Following PCR, plates were analyzed for melting curves with Lightscanner
(Idaho Technology) over a 65-95°C range. From this, WT, heterozygous
and mutant melting temperatures were clearly distinguished. As
previously published (Thomas et al., 2014), HRMA was used to identify
CRISPR-derived esco2 heterozygous mutant F1 zebrafish. HRM primers
were 5′-GCTAGAATCTCCCCCAAAGC-3′ and 5′-AGGGGTTTCTGC-
TTGCTGTA-3′. Genomic PCR encompassing this region was sequenced
from HRM-positive F1 fish, and then desired mutant (+13) fish were
propagated into the F2 generation.
PCR gel genotyping
To confirm melt curve analysis, individual embryo PCR reactions
corresponding to an esco2+/+ (WT), esco2hi2865/+ and esco2hi2865/hi2865
(mutant) melting curve were performed using primers 5′-ACTGCGGGA-
AAAGTGAGAGA-3′ and 5′-TGATTAATTTTTGCCCAGCAC-3′ for WT
products. Primers 5′-ACTGCGGGAAAAGTGAGAGA-3′ and 5′-AAG-
GCACAGGGTCATTTCAG-3′ amplified the viral insertion product, which
was run on a 2% agarose gel.
Microinjection of antisense morpholino and esco2 CRISPR
Injection of p53 morpholino (MO) or esco2 Cas9/guide RNA was
performed on one-cell-stage zebrafish embryos at a concentration using
0.5 nl of 0.85 mM. Injected embryos were incubated at 28°C until the
indicated stage and analyzed via brightfield microscopy. The sequence of
p53 MO used to target exon 2 splice donor site of the p53 gene was 5′-
CCCTTGCGAACTTACATCAAATTCT-3′. Cas9mRNAwas transcribed
from the linearized pT3TS-nCas9n plasmid (Addgene) using the
mMessage mMachine T3 kit (Life Technologies). Each RNA was
purified using the RNeasy Kit (Qiagen). The CRISPR guide RNA was
synthesized using the MegaShortScript T7 Kit (Life Technologies) and
purified using the MegaClear Kit (Life Technologies). RNA concentration
was quantified using the Nanodrop spectrophotometer. For CRISPR/Cas9
injections, 150 ng/µl of Cas9 mRNA and 30 ng/µl of RNA were used
(Thomas et al., 2014).
Quantitative RT-PCR
RNA was extracted from approximately 30 pooled esco2+/+ (AB), esco2
sibling (sib; containing WT and heterozygous embryos) or esco2m/m (based
on mutant phenotype at 24 hpf) embryos using Trizol reagent (Life
Technologies), according to the manufacturer’s suggested protocol. Each
RNA sample was diluted to 10 ng/µl using RNase-free water, and cDNA
was synthesized from each sample using the High Capacity cDNA Reverse
Transcription Kit (Life Technologies). Primers and probes for both esco2
(NM_001003872.1) (primers Y and Z in supplementary material Fig. S1)
andGapdh (NM_001115114.1) were obtained from Life Technologies, and
RT-PCR analysis was performed for each cDNA sample using an ABI
Prism 7900HT Fast Real-Time PCR System. Gene expression was then
calculated using the comparative CT method.
Microscopy and image analysis
Gross morphology, heart and fin imaging
Embryos were placed in 0.4% tricaine to anesthetize and then in methyl
cellulose for proper positioning at indicated time points. DIC images were
taken for the heart and fin, and brightfield images were taken of the gross
morphology. Heart and gross morphology images were taken using a Nikon
AZ100 using the 2× objective 0.5 NA 4× digital zoom (heart) and 2× digital
zoom (gross morphology). Images were processed using NIS Elements
software. Fin images were taken on a Zeiss Axio Observer fluorescent
microscope using a 10×0.2 NA objective and processed with Zen 2011 Blue
software.
Head size and growth area measurements
esco2 heterozygoteswere crossed to generatemutants and analyzed at 24 hpf,
36 hpf, 48 hpf and 72 hpf.Mutants were identified by phenotype and isolated
while esco2 sibs were correspondingly isolated. At each time point, an
individual embryowas placed inmethylcellulose in lateral position. Embryos
were imaged using Nikon AZ100 in at 2× objective and 2× digital zoom. Site
of measurement for the head size was determined by drawing parallel lines
corresponding to head direction and eye placement. From these lines, an
additional perpendicular line that bisects the two parallel lines and the center
of the eye was drawn. It was this line that was measured using the measure
analysis tool in ImageJ using arbitrary units. Embryoswere once again placed
in methylcellulose in lateral positioning. Growth area measurements were
obtained in a similar manner. The full embryo was outlined and the area of
each embryowas quantified. Measurements were obtained by using the same
measure tool in ImageJ using arbitrary units.
Apoptosis assay
Embryos were dechorionated using pronase as stated above and incubated in
10 µl/ml acridine orange for 1 h in the dark. Embryos were washed 5× for
5 min with E3 embryo water. For Fig. 2B, DIC and fluorescence images
were taken on a Zeiss AxioObserver.Z1 using a 20× objective NA 0.4.
Images were processed using Zen Pro 2011 and ImageJ. For Fig. 2C,
fluorescence was observed using Nikon AZ100 using GFP filter at 2×
objective and 2× digital zoom.
Whole-embryo phospho-H3 stain
Embryos staged at 24 hpf were dechorionated using 30 µl pronase (30 mg/ml;
Sigma p5147)/1 ml E3 blue embryo water (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2, 0.33 mMMgSO4, 10
−5% methylene blue). Embryos were
incubated for 10 min in pronase and washed 3× with E3 blue embryo
water to remove chorions. Embryos were then fixed in microtubule fixative
(1× PBS, 37% formaldehyde, 8% glutaraldehyde, 1 M MgCl2, 100 mM
EGTA, and 10% Triton X) at room temperature. After a 2-h block (1× PBS,
DMSO and 10% sheep serum), embryos were incubated overnight with
anti-phospho-H3 (ser10) (Santa Cruz Biotechnology, sc-8656-R) at 1:200
dilution. Embryos were rinsed in block 3× for 20 min and then incubated in
corresponding secondary antibody, goat anti-rabbit Alexa Fluor 647
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(Invitrogen, a21245). Embryos were washed in 1× TBST and placed in
slowfade (Invitrogen) until imaged. All embryos were deyolked using
27-gage needles prior to imaging.
Whole-embryo phospho-H3 imaging
Yolks were removed after fixation for imaging purposes. Whole-embryo
z-stack (1.5 µm interval) confocal imaging was generated using a 5×0.12
NA objective, and on a Leica SP2 upright confocal microscope. Phosphor-
H3 (ser10) embryos were quantified using ImageJ ICTN plugin.
Mitotic profiling
Four non-overlapping fields were imaged per embryo by taking a 1.5-µm
z-stack through whole embryo using the Nikon A1R confocal microscope
using 60×1.4 NA objective. Images were compressed and converted to
black and white for ideal counting/detection conditions. Using morphology
of pH3 staining, the phases of each cell were determined and quantified for
each field (see Fig. 3E). This procedure was done for three embryos of each
genotype. Percentages for each phase were quantified for each embryo,
generating average percentage of each phase/genotype.
Time-lapse imaging
CaaX-mCherry and H2afva-EGFP mRNA was transcribed from a plasmid
[pCS2-CaaX-mCherry and pCS2-H2afva-EGFP; gift from K. Kwan
(University of Utah)] using mMessage mMachine SP6 kit (Life
Technologies). esco2 heterozygotes were crossed and embryos were
microinjected into the yolk of a one-cell-staged embryo with 1 nl of
200 ng/µl Caax-mCherry and 200 ng/µl H2afva-eGFP mRNA. At 24 hpf,
embryos were screened for fluorescence. Embryos were manually
dechorionated using tweezers and anesthetized using 0.4% tricaine. In a
glass-coverslip-bottomed dish, embryos were embedded in a 1% low-melt
agarose. Dishes were placed on the Nikon A1 inverted confocal microscope,
and z-stack images were taken at designated intervals. For AB and esco2
WT videos, 40-µm z-stacks (with a 3-µm interval) were obtained every
2 min for a total scanning time of 2 h. Because esco2 mutants have a
dramatically longer division time, adjustments had to be made to account for
photobleaching and to capture full esco2 divisions from NEB to NER.
Z-stacks were taken every 5 min for a total scanning time of 4 h. All videos
were taken using 60×1.4 NA objectives. 3D viewing, still shots and videos
were assembled and processed using NIS Elements 4.13.00.
Micronuclei/apoptotic bodies count
Embryos were injected with H2afva-EGFP and CaaX-mCherrymRNA and
set up as if for a time-lapse video. To ensure consistency, for each field, a
40-µM z-stack was generated with 2-µm steps using 60×1.4 NA objective
and 1.5 digital zoom on a Nikon A1 confocal microscope. Using 3D volume
rendering in NIS Elements 4.13.00, an average nuclei, micronuclei and
apoptotic body count was calculated per field to generate the percent
observed in a population of cells. Filters for apoptotic bodies and
micronuclei (versus nuclei) were set at H2afva-EGFP fluorescing body
≤3 µm. Differentiation between apoptotic bodies and micronuclei was
determined based on size and localization within the cell; i.e. using the
CaaX-mCherry (plasma membrane) fluorescence, it can be determined
whether a micronuclei is within a cell and whether an apoptotic body is
outside a cell. Frequency of micronuclei in interphase (Fig. 5E) was
calculated by dividing the total number of micronuclei observed in the 3D
render by the number of nuclei identified in the 3D render.
SDS-PAGE and western blot analysis
Cell lysates for immunoblotting were prepared using 18-hpf, 24-hpf and
30-hpf embryos. Embryos were dechorionated using pronase procedure as
stated above. Deyolking was performed by adding 200 µl deyolking buffer
(55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO3), pipetting up and down
three times with a p200 pipette tip and then centrifuged for 2 min at
300 rpm. Supernatant was discarded and the above step was repeated once
more. 60 µl protein prep (30 µl Invitrogen NuPAGE LDS sample buffer,
10 µl proteinase inhibitors, 1.5 µl β-mercaptoethanol, 18.5 µl water) was
added to embryos and put on heat block at 95°C for 5 min. Lysates were
microcentrifuged and put on heat block for an additional 5 min. Supernatant
was transferred to a separate tube and stored at −20°C. Protein was loaded
onto a 4-12% NuPAGE gel (Invitrogen) and transferred to a PVDF
membrane. α-tubulin at 1:7000 (Abcam, ab7291-100) and GAPDH at
1:5000 (Cell Signaling, 2118S) were used as loading controls. Antibodies
used were against pH3 at 1:5000 (Santa Cruz Biotechnology, sc-8656-R),
p53 at 1:1000 (GeneTex, GTX128135) and γ-H2AX at 1:1000 (GeneTex,
GTX127340). All blots were treated with Lumigen PS-3 detection agent.
The pH3 and p53 blots were exposed to film, developed using the Konica
SRX-101A system and imaged using the CareStream 212 Pro imaging
system. The γ-H2AX blot was imaged using the Bio-Rad ChemiDoc MP
imaging system. All digital images were scanned at 600 dpi and quantified
using ImageJ.
Chromosome spreads
Chromosomes spread protocol was adapted from the Lee group (Jeong et al.,
2010). Approximately 20-30 embryos were dechorionated at 24 hpf.
Embryos were incubated in 400 ng/ml nocodazole for 2 h in the dark at
room temperature. Embryos were then transferred to 1.1% sodium citrate in
a 6-cm dish. At this point, for genotyping purposes, tails were removed to be
genotyped, whereas the remaining embryo heads were transferred to fresh
sodium citrate solution and incubated on ice for 8 min. Next, we performed
two washes with a cold 3:1 methanol:acetic acid solution for 20 min each
followed by storage in −20°C until genotyping was performed. After
fixative procedure, embryos were pooled (10-12 embryos/pool) per
genotype and then minced using forceps in a 1:1 methanol:acetic acid
solution. Using this mixture, 50 µl of pooled embryos were dropped onto a
slide, and 3-5 drops of glacial acetic acid was added. The slide was slowly
placed slide up and exposed to hot vapors (we used boiling water) for about
10 s; then the slidewas allowed to dry on a hot metal surface (approx. 50°C).
After the slide was completely dry, a few drops of Prolong Gold with DAPI
were added and covered with a glass coverslip. Chromosomes were imaged
using a 63×1.4 NA objective on a Zeiss Axio Observer fluorescent
microscope and processed with Zen 2011 Blue software. Although most
spreads were clearly delineated into the ‘paired’, PBS or ‘separated’
categories, if a spread had multiple phenotypes it was categorized by which
was most prevalent in that spread. Chromatid number was counted manually
from high-resolution images.
Statistical analysis
Excel software was used in the generation of all graphs and statistical tests.
Overall statistical significance was calculated using an unpaired t-test with
error bars indicating s.d. as stated in legend (±). All P-values were
determined significant at P<0.05. Unpaired t-test determined the
significantly different values. Log-rank test determined significance in
Kaplan–Meier survival curve analysis. Significance values are stated in the
figure legends.
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